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Abstract
Background: Escherichia coli as a frequently utilized host organism for recombinant protein production offers
different cellular locations with distinct qualities. The periplasmic space is often favored for the production of
complex proteins due to enhanced disulfide bond formation, increased target product stability and simplified
downstream processing. To direct proteins to the periplasmic space rather small proteinaceus tags that can be
used for affinity purification would be advantageous.
Results: We discovered that domain D of the Staphylococcus aureus protein A was sufficient for the secretion of
various target proteins into the periplasmic space of E. coli. Our experiments indicated the Sec pathway as the
mode of secretion, although N-terminal processing was not observed. Furthermore, the solubility of recombinant
fusion proteins was improved for proteins prone to aggregation.
The tag allowed a straightforward affinity purification of recombinant fusion protein via an IgG column, which was
exemplified for the target protein human superoxide dismutase 1 (SOD).
Conclusions: In this work we present a new secretion tag that combines several advantages for the production of
recombinant proteins in E. coli. Domain D of S. aureus protein A protects the protein of interest against N-terminal
degradation, increases target protein solubility and enables a straight-forward purification of the recombinant
protein using of IgG columns.
Background
Due to the simple handling, inexpensive fast high-den-
sity cultivation and well-known genetics [1,2], E. coli
remains an attractive host for the production of recom-
binant proteins, even though more complex proteins
with posttranslational modifications, such as glycosyla-
tion patterns require alternative host systems [3,4].
Depending on the characteristics of the target protein,
E. coli offers different compartments to meet the
requirements for successful expression and purification.
Cytoplasmic expression offers high yields of soluble pro-
duct [5], but the purification from the cell lysate can be
complex and costly. High level cytoplasmic overexpres-
sion may lead to the formation of inclusion bodies (IB).
These protein aggregates simplify the purification but
make in vitro refolding necessary [6,7].
In order to make purification easier, protect the target
from degradation, (which is especially a problem with
low molecular weight molecules [8]) or increase the
chance of proper folding, the secretion of the target pro-
tein into the periplasm or the culture medium has pro-
ven to be a strong alternative [9,10]. Translocation of
proteins across the inner membrane requires a signal
peptide. However, the presence of a signal sequence
alone does not ensure secretion into the periplasmic
space [11,12]. Thus, a larger secretion moiety can be
linked to the target gene. It has been shown that the
Staphylococcus aureus Protein A (SpA) secretion signal
combined with miscellaneous Protein A sub-domains
directs heterologous proteins into the periplasm or even
to the culture supernatant [13]. In addition to promot-
ing protein translocation to the periplasm these domains
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tein and to protect against N-terminal degradation [14].
In the present work we show that domain D of SpA
expressed from a synthetic codon optimized gene
(sSpAD) is sufficient for the secretion of recombinant
proteins. Furthermore we propose the Sec pathway
mediating secretion and demonstrate the possibility of a
straightforward one step expression and purification
system.
Results and discussion
Preliminary experiments with the swine fever virus
autoprotease N
proEDDIE [7] showed that protein solubi-
lity was drastically increased with a C-terminal sSpAD
extension, whereas N
proEDDIE fusion proteins with
other tags were deposited as insoluble aggregates within
the cytoplasm [7,15]. Due to the characteristics of pro-
tein A as a surface protein it was assumed that an
N-terminal sSpAD tag might facilitate periplasmic secre-
tion. Therefore a construct with an sSpAD tag upstream
of the autoprotease was cloned and this fusion protein
was expressed under control of the weak lacUV5 pro-
moter in E. coli. As shown in Figure 1 the tag enhanced
the solubility of the aggregate forming protein N
proED-
DIE-pep6His by a factor of three. The soluble fraction
of human superoxide dismutase 1 (SOD), which is a
highly soluble protein per se (95%), was enhanced only
by three percent. However, solubility of GFPmut3.1
even decreased as a fusion with sSpAD. This can be
explained by the observation that E.coli did not tolerate
considerable amounts of GFPmut3.1 in the cytoplasm.
We found the main portion of GFPmut3.1 either in the
periplasm or in inclusion bodies (data not shown). In
fusion with sSpAD the expression rate was increased
even further. The additional amount of protein was
mostly deposited in inclusion bodies and only a minor
part exported to the periplasm (data not shown). This
led to a slightly increased export but to an overall
reduced solubility.
Subsequent isolation of the periplasmic fraction by
osmotic shock treatment revealed the ability of the
sSpAD moiety to mediate secretion. The different cell
compartments were isolated according to the manual
published by Paal et al. [16]. There are two main secre-
tion pathways, known to mediate protein translocation
across the inner membrane [17]. A number of specific
inhibitors were used to distinguish between passive dif-
fusion and active secretion by means of the Sec or Tat
pathway.
Identification of the secretion pathway
In order to identify the secretion pathway the fusion
construct sSpAD-N
proEDDIE-pep6His was expressed
under control of the strong T5 promoter. This promoter
enabled the expression of detectable protein amounts in
the presence of toxins, such as carbonyl cyanide m-
chlorphenylhydrazone (CCCP) within short incubation
times in different host strains.
Several secretion pathways can be analyzed using
diverse protonophores and knockout strains. CCCP has
the ability to specifically inhibit all proton motive force
driven pathways in E. coli [18,19]. To test if sSpAD
secretion was driven by any of these pathways the
recombinant fusion protein was expressed and cultivated
in the presence of CCCP. As shown in Figure 2A, CCCP
inhibited secretion into the periplasm. The slight signal
in the periplasmic fraction could be considered as an
artefact because minor expression of the recombinant
protein occurs even before induction and addition of
CCCP. Thus the signal in the periplasmic fraction was
most likely due to secretion before inhibition of the
given secretion pathway. Immuno blots against GroEL
were performed to confirm the integrity of the sphero-
plasts. GroEL is a cytoplasmic chaperone, which was not
found in the periplasm (Figure 2B). Anti Maltose bind-
ing protein E (MalE) immuno blots were performed to
verify the isolated fractions as periplasm of E. coli cells
(Figure 2C).
DADE is a MC4100 derived Tat knock-out strain lack-
ing a functional Tat pathway [20]. This strain was used
to show if sSpAD secretion was Tat dependent. Subcel-
lular fractions showed that Tat knockout had no effect
on the secretion capacity of the fusion protein shown in
Figure 2A. Therefore, the involvement of the Tat path-
way in the secretion process was excluded.
Sodium-azide is a strong inhibitor of the ATPase SecA
and therefore has the ability to specifically inhibit the
Figure 1 Comparison of the protein solubility with and without
sSpAD tag. The solubility of N
proEDDIE-pep6His, SOD and
GFPmut3.1 with and without sSpAD tag, expressed under the
control of a LacUV5 promoter, was determined under defined
cultivation conditions.
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with sodium-azide indicated an inhibition of transloca-
tion, although, recombinant expression artefacts were
observed in the periplasmic fraction due to the osmotic
shock procedure. Therefore, experiments were per-
formed in parallel, using the target protein with and
without the secretion tag to determine the background.
The densitometric comparison of the amount of recom-
binant protein with and without sSpAD-tag in the peri-
plasmic fraction confirmed that sodium-azide inhibited
secretion. Continuative experiments were performed
with the SecE knock-out strain CM124 [21]. As the Sec
pathway is crucial for cell viability, SecE was comple-
mented via expression from an L-arabinose induced
plasmid. Over-night (including L-arabinose) culture was
split, diluted and subsequently cultivated with and with-
out L-arabinose. After dilution the culture without L-
arabinose should have no functional Sec pathway. As
s h o w ni nF i g u r e3t h ek n o c k o u to ft h eS e cp a t h w a y
inhibited secretion of the target protein. These experi-
ments led to the assumption that the Sec pathway
s e e m st ob ei n v o l v e di ns o m ew a yi nt h ee x p o r to f
sSpAD fusion proteins to the periplasm; however the
SignalP 3.0 prediction tool http://www.cbs.dtu.dk/ser-
vices/SignalP did not reveal a canonical Sec secretion
signal. The recent advances in genomics and proteomics
revealed numerous extracellular proteins lacking defined
secretion signals [22], often combining functions within
the cytoplasm and in the extracellular environment [23].
Possibly, the elevated levels of expression of the sSpAD
tagged proteins could lead to an emergency mechanism,
which exports proteins through the Sec channel without
using a signal sequence.
Quantification of the secretion capacity
The fusions of sSpAD to the pestiviral autoprotease
N
proEDDIE-pep6His, to green fluorescent protein
GFPmut3.1 and to human superoxide dismutase 1
(SOD) produced by shaking flask cultivation were quan-
tified by densitometry of SDS-PAGE as described in
Methods. Since the fusion tag was not cleaved after
secretion, it was not possible to distinguish easily
between secreted and non-secreted proteins. Preliminary
experiments showed that overexpressed proteins lacking
export signals were detected in the periplasmic fraction.
Therefore all recombinant proteins were expressed with
and without sSpAD tag and the periplasmic fractions of
all samples were isolated. Subsequently, the concentra-
tions of the target proteins in the periplasm of all sam-
ples were measured and the amount found in the
Figure 2 Secretion competence of an sSpAD fusion protein.A :T h es S p A Dt a gr e a c t sw i t hm o s ts e c ondary antibodies. Therefore sSpAD
fusion proteins were detected on the same membrane as GroEL immuno blots. For the sSpAD immuno blots a secondary antibody was used
which reacts against sSpAD. B: Anti GroEL immuno blots of the isolated fractions were performed to confirm that the periplasmic fractions
obtained via osmolysis, were not contaminated with cytoplasmic proteins. C: Anti MalE immuno blots were performed to confirm that the
isolated fractions correspond with the periplasm as the Maltose Binding Protein E is a periplasmic protein. -I: whole cell sample without
induction of recombinant protein expression, +I: whole cell samples with induction of recombinant protein expression, P periplasmic fraction,
C: cytoplasmic fraction; CCCP: carbonyl cyanide m-chlorophenylhydrazone, BL21(DE3): host strain, DADE: ΔtatABCDΔtatE host strain derived from
MC4100.
Figure 3 Identification of the secretion pathway. In the CM124
strain Sec mediated secretion is inducible via addition of L-
arabinose. Incubation times were kept very short to ensure cell
viability of the cell culture without functional Sec pathway.
Furthermore, low expression levels of the recombinant protein
prevent contamination of the subcellular compartments due to
overexpression of the target protein. Therefore, the subcellular
localization of N
proEDDIE was determined via immuno blot. GroEL
immuno blot was performed to control osmolysis mediated cell
lysis. -I: whole cell sample without induction of recombinant protein
expression, +I: whole cell samples with induction of recombinant
protein expression, P: periplasmic fraction, C: cytoplasmic fraction.
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of proteins secreted with the sSpAD tag. The corrected
secretion capacities are given in Table 1. The secretion
yields for sSpAD-SOD (16.4 mg/L) and sSpAD-N
proED-
DIE-pep6His (11.3 mg/L) were well above the reported
yield for Sec mediated secretion [9]. However, in con-
trast to N
proEDDIE-pep6His (not detectable in the peri-
plamic fraction) and SOD (approximately 30 percent in
the periplamic fraction), a major part of GFPmut3.1 was
found in the periplasm, although the lack of the cyto-
plasmic chaperone GroEL indicated intact spheroplasts.
Due to expression of GFPmut3.1 from a codon-
optimized gene the protein level of GFPmut3.1 was
rather high and increased even with the sSpAD tag.
Therefore it was assumed, that these high expression
levels provoked a passive diffusion of GFPmut3.1 into
the periplasm.
One step secretion and purification
In order to exemplify the quick and easy purification of
fusion proteins the periplasmic fraction of a 10 ml shak-
ing flask cultivation of sSpAD-SOD was purified. The
sample was applied on an IgG column as described in
Methods. After a single purification step 16.9 mg/L of
the purified fusion protein could be obtained (Figure 4).
This was in good agreement to the amount found by
determination of the secretion capacity (16,4 mg/L).
Conclusions
The main advantage of this system is the applicability
for a variety of different proteins and the improved yield
of soluble product. Especially for aggregate forming pro-
teins this tag provides an alternative to common solubi-
lity tags such as GST and MBP. In terms of secretion of
heterologous targets, a typical Sec signal sequence is
often not sufficient to promote the transport across the
inner cell membrane. The sSpAD tag tends to enhance
the solubility of aggregate forming fusion partners,
which results in an improved secretion of the target
protein. This was exemplified by the autoprotease N
pro,
a cystein rich protein, which does not secrete with a sin-
gle Sec signal peptide (data not shown). Furthermore,
the tag facilitates a straight-forward one step purification
of the target protein, which was shown by the purifica-
tion of sSpAD-SOD. Since sSpAD was not processed
during Sec mediated secretion a proteolytic cleavage of
the tag is necessary. Screening of sSpAD with the Sig-
nalP 3.0 prediction tool did not result in the detection
of an intrinsic secretion signal. With an overall length of
7 kD the tag does not suit the classic Sec signal
sequence. Therefore, it is proposed that sSpAD is not
cleaved by the signal peptidase and possibly activates
the SecA translocation by its conformation. Further
dissection of sSpAD may identify an intrinsic secretion
signal, which still facilitates an affinity-mediated
purification.
Methods
All experiments were performed with Milli-Q ultrapure
water (Millipore purification system). E. coli cells were
cultivated in TY growth medium supplemented with
50 μg/ml kanamycin and/or 100 μg/ml ampicillin
depending on the used plasmid. For recombinant plas-
mid isolation E. coli K12 DH5a strain was used, whereas
protein expression was performed in BL21(DE3),
CM124 (ΔSecE with SecE under control of the araBAD
promoter placed on a plasmid) and MC4100-DADE
(ΔtatABCDE).
Restriction enzymes, GoTaq® DNA polymerase,
including the PCR buffer, were obtained from Promega.
Molecular mass standard used for SDS-PAGE, rapid
DNA ligation kit, Pfu DNA polymerase and 10x
MgSO4-PCR buffer were obtained from Fermentas.
Tris-Glycine gels were purchased from Invitrogen. Pro-
tran BA 83 nitrocellulose membrane was obtained from
Whatman. Mouse anti-GroEL monoclonal antibody was
purchased from Stressgen Bioreagents, Goat anti-Mouse
IgG (HRP conjugated) from Invitrogen, anti-Maltose
Binding Protein (MBP) monoclonal antibody (HRP con-
jugated) and anti-Maltose Binding Protein (MBP) poly-
clonal antibody from New England Biolabs. Anti-N
pro
antibody was generated within the Austrian Center of
Table 1 Secretion capacity of the fusion proteins
Vectors Fusion Protein Secretion Capacity
pLacUV5
a sSpAD-N
proEDDIE-pep6His 11.3 mg/L
pLacUV5 sSpAD-Gfpmut3.1 1.3 mg/L
pLacUV5 sSpAD-SOD 16.4 mg/L
a pET30a plasmids with the lacUV5 promoter are named pLacUV5
Figure 4 I g Gc o l u m np u r i f i c a t i o no fa ns S p A D - f u s i o np r o t e i n .
sSpAD-SOD was purified out of the periplasmic fraction of a
shaking flask cultivation in BL21(DE3). P: periplasmic fraction, Fl: flow
through, W: washing step, E1-E4: eluted fractions.
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Syringe filters (pore size 0.45 μm) were from Sartorius,
10 kDa molecular weight cut-off ultrafiltration devices
(Centriprep Ultracel YM-10 tubes, series 8000 stirred
cell including Ultracel YM-10 membranes) from Milli-
pore. The BCA™ protein assay kit was obtained from
Pierce.
Construction of expression plasmids
The pET30a T7 promoter (T7p) was replaced by three
alternative promoters e.g. T5, the artificial Tac promoter
and the lacUV5 promoter resulting in the three vectors
pT5, pTac and pLacUV5. Two oligonucleotides corre-
sponding to the given promoter sequence with comple-
mentary bases, prom lacUV5 SphI F and prom lacUV5
XbaI R, were directly ligated into an SphI and XbaI
digested pET30a plasmids. The Tac promoter, consisting
of two oligonucleotides with 65 complementary bases,
prom Tac SphI F and prom Tac XbaI R, was directly
ligated into SphI and XbaI digested pET30a plasmids.
The T5 promoter was generated by PCR with the given
primers in Table 2 and subsequently cloned into SphI
and XbaI digested pET30a plasmids.
Codon optimized GFPmut3.1 gene was amplified
using the primers sGFP F NdeI start and sGFP R (Table
2). The amplified fragment was ligated into NdeI and
SalI digested pLacUV5 vector, resulting in pLacUV5-
GFPmut3.1 plasmid.
The sSpAD signal sequence was codon optimized
(sequence given in the appendix 1) and amplified using
the primers pET30 sSpAD NdeI F and pET30 sSpAD
NdeI R. Subsequently sSpAD was subcloned into the
pLacUV5 GFPmut3.1 vector resulting in the pLacUV5-
sSpAD-GFPmut3.1.
The sSpAD-N
pro-EDDIE-pep6His construct was gen-
erated by digestion with NdeI of the pET30 N
pro-
EDDIE-pep6His vector and subsequent ligation with the
same insert generated for the pLacUV5-sSpAD-
GFPmut3.1 construct. Subsequently the promoter of the
pET30-sSpAD-N
pro-EDDIE-pep6His construct was
replaced with the promoter LacUV5.
The pLacUV5-sSpAD-SOD plasmid was generated in
two steps. First sSpAD was amplified using the primers
pET 30 sSpAD NdeI F and pLacUV5 sSpAD NheI R
and cloned into the pLacUV5 vector, which resulted in
the pLacUV5 vector with an additional NheI restriction
site. Subsequently the codon optimized SOD gene was
amplified using the primers SOD NheI F and SOD SalI
R (Table 2). The amplified fragment was ligated into the
pLacUV5-sSpAD-Nhe vector, which was digested with
NheI and SalI, resulting in pLacUV5 sSpAD-SOD plas-
mid. A list of the constructs is given in Table 3.
Shake flask cultivation
Expression plasmids were transformed into E. coli BL21
(DE3), subsequently a single colony was picked to
inoculate overnight cultures. These cultures were diluted
1:20 with fresh TY-medium, supplemented with 0.5%
glucose and grown to a density of OD600: 1.0 at 37°C/
225 rpm. Recombinant protein synthesis was induced
adding 1 mM IPTG. Expression with T5 promoter was
carried out for 1 h at 37°C/225rpm in BL21(DE3), BL21
(DE3) with 2 mM NaN3, BL21(DE3) 50 μM CCCP. For
the shake flask cultivation with E. coli DADE experi-
mental procedure was similar to E. coli BL21(DE3) but
without addition of glucose during cultivation.
In contrast overnight cultures of CM124 cells carrying
pET30-Tac-promoter-plasmids were grown in the
Table 2 Oligonucleotides used in this study
Primers Sequences (5’-3 ’)
pET 30 sSpAD NdeI F GCACGACATATGGCAGACGCACAACAGAATAAG
pET 30 sSpAD NdeI R TAGCAGCATATGTTTTGGTGCCTGGAGTTC
pLacUV5 sSpAD NheI R GCAAGCTAGCTTTTGGTGCCTGAGATTCGTTC
SOD NheI F TAAAGCTAGCGCGGCAACAAAGGCCGTGTG
SOD SalI R AGTTGTCGAC TTGGGCGATCCCAATTACACC
sGFP F NdeI GGATCCACTCATATGAGCAAAGGCGAAG
sGFP R CGAGGTCGACTTATTATTTATACAGTTCATC
prom Tac SphI F 5’P-CGAGCTGTTGACAATTAATCATCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTT
prom Tac XbaI R 5’P-CTAGAAATTGTTATCCGCTCACAATTCCACACATTATACGAGCCGATGATTAATTGTCAACAGCTCGCATG
prom LacUV5 SphI F 5’P-CCCAGGCTTTACACTTTATGCTTCCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTT
prom LacUV5 XbaI R 5’P-CTAGAAATTGTTATCCGCTCACAATTCCACACATTATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGCATG
T5 Prom SphI F GGCGGCATGCGAAATCATAAAAAATTTAT
T5 Prom XbaI R TTTCTAGATGTGTGAAATTGTTATCCGCT
a The oligonucleotides contain the letters: F - forward or R - reverse
5’P represents a 5’Phosphate group modification
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were diluted 1:20 and split. The divided cultures were
grown with and without 0.2% L-arabinose in parallel.
Expression was induced at OD600:0 . 5w i t h1m M
IPTG and the cultures were incubated for 1 h at 37°C/
225 rpm.
For the determination of the solubility and the secre-
tion capacity overnight cultures of the host strain BL21
(DE3) carrying the pET30-LacUV5-promoter plasmids
were diluted 1:20. Expression was induced at OD600:0 . 5
with 1 mM IPTG and the cultures were incubated for
2 h at 37°C/225 rpm.
Cell fractionation
Isolation of the periplasm was performed at 24°C with a
gentle osmotic shock procedure to minimize E. coli cell
disruption during preparation (modified from [15]).
After expression, a culture volume corresponding to 10
ml of OD600 2.0 was centrifuged at 3000 g for 10 min.
The pellet was completely suspended in one culture
volume of osmolysis buffer (100 mM TRIS-HCl pH 7.8,
15.4% sucrose, 3 mM EDTA) and incubated at 50 rpm
for 10 min, followed by centrifugation. The supernatant
was discarded and the pellet was resuspended in one
culture volume water and incubated for 10 min at
50 rpm. Afterwards the suspension was centrifuged for
10 min at 3000 g. The supernatant, containing periplas-
mic proteins, was decanted and filtrated (membrane,
0.45 μm pore size). The spheroplasts were kept as a cel-
lular fraction. For SDS-PAGE analysis periplasmic and
cytoplasmic fraction samples were precipitated with
TCA and all pellets solubilised in loading buffer (62.5
mM Tris-HCl pH 6.8, 10% glycerol, 2% SDS, 0.0025%
bromophenol blue, 50 mM DTT).
For the determination of the solubility the cells were
taken up in a culture volume lysis buffer (20 mM
Na2HPO4 pH 8.0, 75 mM NaCl, 5 mM EDTA) and dis-
rupted with a French press (American Instruments Co.,
Inc). Aliquots of the lysate were collected and centri-
fuged at 14000 rpm for 15 min. The supernatant con-
tained soluble cytoplasmic protein, whereas the pellet
represented the insoluble protein fraction. For SDS-
PAGE analysis the samples were precipitated with TCA
and all pellets solubilized in loading buffer (62.5 mM
Tris-HCl pH 6.8, 10% glycerol, 2% SDS, 0.0025% bro-
mophenol blue, 50 mM DTT).
Concentration and purification of recombinant protein
To the filtrated periplasm fraction Na2HPO4/NaH2PO4
and NaCl were added to a final concentration of 20 mM
Na2HPO4/NaH2PO4, 500 mM NaCl, pH 8. 10 ml of this
solution were concentrated to 2 ml with ultrafiltration
devices. After removal of precipitated proteins by centri-
fugation, the supernatant was applied to a pre-equili-
brated 500 μl gravity flow IgG-NHS-Sepharose column
and purified. The column was washed with 2.5 ml 20
mM Na2HPO4/NaH2PO4 500 mM NaCl pH 8 buffer.
The recombinant protein was eluted with 5 column
volumes of 0.2 glycine buffer pH 3. The eluted fractions
were pooled and the total concentration of the purified
protein was quantified.
Immuno blots
Cellular integrity after expression of the recombinant
proteins and subsequent osmotic shock treatment was
surveyed by Immuno blot analysis with antibodies
against the periplasmic Maltose binding protein MalE,
and the cytoplasmic chaperone GroEL. Cell fraction
samples were separated on 4-20% Tris-Glycine gels and
the proteins electrophoretically transferred onto nitro-
cellulose membranes. Incubation times of the antibodies
were carried out according the instruction manuals.
Protein quantification
Quantification of the secretion capacity was carried out
by densitometric analysis of target proteins in compari-
son to BSA standards on Coomassie stained gels. Gels
were photographed and analyzed with AlphaEaseFC
software (Alpha Innotech Corporation).
Appendix 1
Accession numbers
GFPmut3.1 [P42212]; SOD [BT008028.1]; Staphylococ-
cal Protein A[P38507]:Domain D:
Table 3 Plasmids and corresponding expression products
Vectors
a,b,c Gene cloned Resulting vectors Expression product
pT5
b sSpAD-N
proEDDIE-pep6His pT5 sSpAD-N
proEDDIE-pep6His sSpAD-N
proEDDIE-pep6His
pTac
c sSpAD-N
proEDDIE-pep6His pTac sSpAD-N
proEDDIE-pep6His sSpAD-N
proEDDIE-pep6His
pLacUV5
a sSpAD-Gfpmut3.1 placUV5 sSpAD-Gfpmut3.1 sSpAD-Gfpmut3.1
pLacUV5 sSpAD-SOD placUV5 sSpAD-SOD sSpAD-SOD
a pET30a plasmids with the lacUV5 promoter are named pLacUV5
b pET30a plasmids with the T5 promoter are named pT5
c pET30a plasmids with the Tac promoter are named pTac
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FIQSLKDDPSQSTNVLGEAKKLNESQAPK N
proEDDIE
[7]
DNA sequence sSpAD (codon optimized):
GCAGACGCACAACAGAATAAGTTTAACAAAGA
CCAGCAGAGCGCATTCTACGAAATTCTGAACAT
GCCGAATCTGAATGAGGAACAACGTAATGGCT
TTATTCAGTCTTTAAAAGACGACCCATCTCAGA
GCACCAACGTTCTGGGCGAAGCAAAGAAACTG
AACGAATCTCAGGCACCAAAA
Abbreviations used
sSpAD: Staphylococcus aureus Protein A domain D expressed from a
synthetic (codon optimized) gene; BL21(DE3): host strain; CCCP: carbonyl
cyanide m-chlorophenylhydrazone; DADE: host strain derived from MC4100
ΔtatABCD, ΔtatE; DTT: dithiothreitol; EDTA: ethylene-diamine-tetra-acetic acid;
GroEL: chaperone heat shock protein 60; GFP: Green fluorescent protein;
IPTG: isopropyl-b-D-thiogalactopyranoside; MalE: maltose binding protein E;
NaN3: sodium-azide; PCR: polymerase chain reaction; SDS: sodium dodecyl
sulphate; SOD: Human Superoxide Dismutase 1; TCA: trichloro acetic acid;
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